Background: Epidemiological and dietary intervention studies suggest that a low-glycemic index (GI) diet is beneficial for blood glucose control; however, long-term clinical utility of the low GI diet has not been fully investigated. Objectives: To evaluate the feasibility and efficacy of a nutritionist-delivered low-GI dietary intervention, with the support of a personal digital assistant (PDA), for adult patients with poorly controlled type II diabetes. Method: The low-GI intervention consisted of six counseling sessions and the use of a PDA-based food database with GI scores for 6 months. Study outcomes included feasibility measures, glycosylated hemoglobin levels (HbA1c), GI and glycemic load (GL) score of self-reported dietary intake, body weight, depression and quality of life (QOL). Measures were obtained at baseline, 3 and 6 months. Results: Of 31 adult patients approached, 15 met study eligibility criteria and were enrolled in the study. Thirteen patients (87%) completed all study assessments. Findings included decreases in average HbA1c (À0.5% P ¼ 0.02), body weight, hip circumference, blood pressure, dietary GI and daily caloric intake. Diabetes impact scores also decreased. All but one participant completed all components of the intervention. There were mixed reports regarding the usefulness of the PDAs; however, participants offered helpful suggestions for further development. Conclusions: Results of this pilot study support the feasibility of implementing a nutritionist-delivered, PDA-assisted low-GI dietary intervention for patients with poorly controlled type II diabetes. Encouraging initial efficacy data require further testing in the context of a randomized clinical trial.
Introduction
The glycemic index (GI) is based on a ranking of carbohydrate-containing foods according to the rate at which they raise blood glucose levels after eating (Jenkins et al., 1981) . A recent meta-analysis of randomized clinical trials (RCTs) (Brand-Miller et al., 2003a) suggests that choosing low-GI foods has a modest but clinically useful effect on mediumterm glycemic control in patients with type II diabetes. However, in most of the published RCTs, patients were fed experimental diets, leaving controversy over the applicability of GI-based diets in the clinical setting for the management of diabetes. The American Diabetes Association (ADA) states that evidence is lacking to support a change in dietary recommendations which are based on carbohydrate counting (Franz, 2003) . One of the barriers to implementation of a low-GI diet among diabetic patients is the relative complexity involved in ascertaining the GI score of each food or meal; whereas carbohydrate counting is much more familiar, and available on every label or through averages from the exchange list (Franz, 2003) . Carbohydrate counting and use of a low-GI diet are not mutually exclusive; thus, integrating a low-GI diet with carbohydrate counting may be optimal for glycemic control.
Advances in the technology of personal digital assistants (PDAs) including smaller size, user friendliness, familiarity, easily modifiable software, and lower cost have contributed to their increasing use in psychological and medical studies since the early 1990s. PDAs have successfully assisted selfmonitoring in studies of diabetes (Clarke et al., 1995) , respiratory diseases (Tiplady et al., 1997) , panic disorder (Taylor et al., 1990) , smoking cessation (Shiffman et al., 1996) , effects of night shift work on psychological symptoms during the menstrual cycle (Totterdell et al., 1995) and menstrual cycling (Johannes et al., 2000) . PDAs might also reduce the burden of GI self-monitoring in the management of diabetes.
The objectives of this study are to evaluate the feasibility of implementation and explore the potential efficacy of a nutritionist-delivered low-GI dietary intervention in a sample of patients diagnosed with type II diabetes, which was poorly controlled. Outcomes of interest included patient completion of intervention sessions, relevant physiological variables (glycosylated hemoglobin (HbA1c), blood pressure and weight), dietary intake and quality of life (QOL) measures.
Subjects and methods

Subject recruitment and enrollment
The study protocol was approved by the University of Massachusetts (UMass) Medical School Institutional Review Board for use of human subjects in medical research. All study participants provided informed consent before being enrolled into the study.
UMass Memorial Health Care patients with a diagnosis of type II diabetes were recruited between July and October 2004 through referrals from a network of participating health-care providers. Eligibility criteria included: having a diagnosis of type II diabetes and having an HbA1c level of 7.0% or greater. We did not include fasting glucose levels as an inclusion criterion, as we were interested in the long-term control of blood glucose which is reflected in HbA1c. Exclusion criteria included: planning to become pregnant or to relocate during the study period, being pregnant, inability to provide informed consent, being on glucocorticoid therapy within the previous 3 months, having experienced an acute coronary event within the previous 6 months, having a diagnosis of a medical condition that precluded adherence to study dietary recommendations, that is, Crohn's disease, ulcerative colitis, end-stage renal disease, diagnosis of a severe psychiatric illness, significant visual impairment or currently following a lowcarbohydrate, high-fat diet such as the Atkins Diet (Atkins, 1998) . Because the Atkins diet is low in all sources of carbohydrates, modification of the type of carbohydrate (GI) will have limited effect on glycemic load (GL) and therefore HbA1c.
Study design and intervention format
This was a pilot study with a single treatment arm. The goal of the intervention was to improve HbA1c levels via a low-GI diet that was customized to the participant's taste preferences and eating habits. The 6-month nutritionist-delivered low-GI dietary intervention consisted of two group sessions, one individual session and three telephone counseling sessions. All participants received a Palm Zire 21 PDA to use for the duration of the study.
The initial 2.5 h group session was held in a demonstration kitchen by a trained nutritionist and involved information on low-GI diet. Factors that influence the GI value of a food (i.e., acid, particle size, fiber content and cooking time), how to integrate a low-GI diet into one's life, and low-GI substitutions for common high-GI foods were discussed. The group then sampled low-GI foods, were provided with low-GI recipes and given hands-on training in the use of the PDA. At the subsequent 1-h individual visit with a nutritionist 2 weeks later, low-GI diet information was reviewed and patient-centered counseling was provided to facilitate the following behavior change strategies: goal-setting, selfmonitoring and problem-solving to address each patient's adherence barriers (to diet or use of the PDA). At the individual visit, participants' PDA data were uploaded to our study database; these data were used by the nutritionist to guide the nutritional counseling. The group reconvened for a 2-h grocery store tour at week 4. Subsequent 30-min telephone counseling sessions with the nutritionist were completed at 2-, 3-and 5-month time points. These sessions addressed the progress towards goals and challenges to adherence.
Low-GI diet and PDA GI database Patients were trained to locate and record individual foods in their diets on the PDA. The Glycemic Index Meal Planner software was provided by the Glycemic Diet Software, LLC (http://www.glycemicdietsw.com). Study investigators provided the software company with nutrient and GI values for food equivalent to those from the International Table of GI (Foster-Powell et al., 2002) , as well as those on 400 additional foods that are commonly consumed by Americans (Ma et al., 2005 (Ma et al., , 2006 . The Meal Planner can be accessed easily from the PDA home screen. Once in the program, the patient can choose breakfast, lunch, dinner, or snack as the meal type, and then select the food group from a list. Foods in the selected group will be displayed, along with the GI score or calories per serving. The ranges for high (469), medium (56-69), and low (o56) GI values are displayed to assist the patient in choosing foods (Foster-Powell et al., 2002; BrandMiller et al., 2003b) . The software calculates the overall GI for individual meals and for the entire day. It also provides carbohydrate, calorie, protein, fat, fiber and sodium intake analysis by meal and by day. The program has the capacity to store up to 30 days of data, and data can be uploaded to external databases (via cradle). Patients can view a log which displays the GI, GL, carbohydrate content and calories for each of the last 30 dates on which they have entered meal data. The software also allows patients to view data on meals and individual foods eaten on each of the dates. At the telephone counseling sessions, the nutritionist reviewed the log with participants, and identified days with high GI. Specific high-GI foods eaten on that day could be identified.
Assessment of study outcomes
The study data collection period was 6 months. Feasibility of study implementation was assessed based on retention rate and attendance records. Treatment acceptability was assessed via questionnaire at the end of the study.
Data were collected at baseline, and then 3 and 6 months following study enrollment and included: HbA1c, blood pressure, body weight, height, waist and hip circumference and medication use; behavioral measures such as dietary intake and physical activity level; and psychosocial measures including QOL and depression.
Fasting blood samples were used to assess HbA1c. Weight and height were measured using a balance beam scale, with participants wearing light clothing and no shoes. Blood pressure measurements were taken using a Dinamap XL automated blood pressure monitor (Sturrock et al., 1997) , which allows standardized measurements.
Dietary intake was assessed by the Seven-Day Diet Recall (7DDR) (Hebert et al., 1997b) . The 7DDR also included a brief validated physical activity assessment, described elsewhere (Matthews et al., 1997 (Matthews et al., , 2000 . The GI score was determined from the intake data collected through the 7DDR using published tables (Foster-Powell et al., 2002; Brand-Miller et al., 2003b) . GI and GL (GI of a food times the amount of carbohydrate in grams eaten divided by 100) were also calculated, as in previous reports (Ma et al., 2005 (Ma et al., , 2006 .
Use of oral hypoglycemics, insulin, lipid-lowering and antihypertensive medications was assessed using a questionnaire at each study visit (baseline, 3 and 6 months).
Depression was assessed using the Center for Epidemiological Studies-Depression Scale (CES-D) (Radloff, 1977; Devins and Orme, 1985) and QOL was assessed using the Diabetes Impact Survey (Schwartz et al., 2005) . Age, gender, education, occupation, ethnicity, income data and diabetic complications were collected by questionnaire at baseline.
Statistical analyses
Demographic data were summarized using mean (s.d.) or frequency (%) as appropriate. For physiological, dietary, physical activity and psychosocial variables, mean and standard deviation (s.d.) were computed at baseline. We conducted longitudinal analyses to evaluate within-participant change over time in physiological, dietary, physical activity and psychosocial variables, using linear mixed modeling (Littell et al., 1996) . Consistent with our previous longitudinal analyses of HbA1c (Rosal et al., 2005) , we employed compound symmetry for the within-subject covariance structure, estimating subject-specific intercepts, that is, subject was considered to be a random effect. Each variable was modeled as a function of categorized time (baseline, 3 and 6 months). Within-subject changes between each of the three time points were estimated, to assess both short-term and long-term changes, and stability between 3 and 6 months.
Results
Of the 31 patients approached for the study, 15 met eligibility criteria and were enrolled. Major reasons for ineligibility were HbA1co7 (eight subjects). We could not assess eligibility for two subjects because of inability to contact the patients. Two subjects indicated they were too busy to participate, and one subject was excluded for each of the following reasons: planned to have weight loss surgery, moving out of the area within 6 months, had type I diabetes, and already on low-GI diet. Of the subjects recruited, 15 were enrolled in the study with one participant dropping out after the first group session owing to job relocation. In addition, one patient was excluded from the final analysis owing to a diagnosis of advanced breast cancer during the study and subsequent inability to adhere to the low-GI diet. Thirteen patients completed the study and their data were used for the analysis. Of these, all but one completed all components of the study intervention (one subject missed two telephone counseling sessions).
Participants' characteristics are presented in Table 1 . They were predominately white, married and well-educated. The average age was 58 years with a range of 39-72 years. Nine men and four women participated. The majority worked full-time and all but one had an annual household income of $60 000 or more. Eighty-five percent of the participants reported diabetic complications, the most common being hypertension, neuropathy and heart disease. However, the majority of participants characterized their health as 'very good' or 'good'. In addition, most (10 out of 13) of the participants had first-degree relatives with diabetes. All participants were being treated with diet and medication. When asked at the beginning of the study if they thought the PDA would be helpful in tracking their diet, all participants answered 'yes'.
The average baseline HbA1c was 8%. Most (nine out of 13) participants' HbA1c levels decreased over the course of the intervention (Table 2 ). For the group as a whole, the decrease in HbA1c was 0.5%, which is clinically significant. There was a statistically significant decrease in HbA1c levels at both the 3-month (P ¼ 0.02) and 6-month (P ¼ 0.02) time points for the overall group compared to baseline. HbA1c remained stable between 3-and 6-month visits (P ¼ 0.98).
Oral hypoglycemic medications at baseline visit included metformin (used by five subjects or 38%), pioglitazone (31%), glyburide (25%), rosiglitazone (15%), and glimepiride (8%). Five subjects (38%) were on insulin. Over the course of the study, several participants reported medically supervised changes in their diabetes treatment (Table 2) . Two decreased their insulin dosage, one discontinued an oral hypoglycemic agent and one decreased oral hypoglycemic dosage. Two participants switched oral hypoglycemic agents, one started taking an additional oral hypoglycemic agent and one began using insulin. When grouping the study results in a category of 'effective GI intervention', meaning either improved in HbA1c, associated with no change in medication or no change in HbA1c associated with a decrease in medication dosage (a total of seven subjects), the average decrease in HbA1c in this subgroup was À5.1% at 3 months and À3.5% at 6 months as compared to baseline. Four subjects in this group (60%) decreased their medication dosage, or the number of medications. On the other hand, in the group where medication dosage was increased, and/or HbA1c increased during the study period (n ¼ 6), categorized as 'not-effective GI intervention', HbA1c increased by 4.1% at 3 months and 1.2% at 6 months, as compared to baseline. Three of these patients (50%) required increased dosage of medication or addition of a different medication. . Forty-four percent of calories were from total fat and 35% were from carbohydrate. Weight decreased by an average of 1.8 kg over the course of the study but this was marginally statistically significant owing to the small sample size (P ¼ 0.07). Systolic and diastolic blood pressure also decreased over the 6-month period (À7.6 and À6.1 mm Hg on average, respectively), the latter attaining statistical significance. Hip circumference decreased significantly over the 6 months for the group overall (À1.9 cm, P ¼ 0.03); however, waist circumference did not change significantly during the study period. Most (nine out of 12) participants' dietary GI decreased from baseline at 3 months but this change did not reach statistical significance. However, when we examined the change of GI at the individual level, we noted that one subject's GI score increased by 24 units at the 3-month time point, which affected the overall significance of the change in GI score for the entire group; when we excluded from the analysis the GI value from this subject, the average GI decreased by 4 units for the group as a whole, at 3 months (P ¼ 0.05). Daily calorie intake also decreased, with a mean reduction of 185 kcal at 6 months, but this reduction was not statistically significant. Depression scores were stable over the course of the study but a decrease in the diabetes impact score was observed and was marginally significant at 6 months (P ¼ 0.09), indicating a better QOL. Participants completed a questionnaire at the end of the intervention to assess acceptability of the intervention. Most participants (11 out of 13) reported that they liked the intervention. Three reported that they had difficulty adhering to the lower-GI diet, three were neutral and seven found it easy, with all participants but one reporting that they liked the low-GI diet. Opinions about the PDA database were mixed. Eight (62%) participants reported that it was difficult to use owing to inability to find all the foods they consumed, 
Discussion
This study provides encouraging data regarding the feasibility of a nutritionist-delivered low-GI intervention, assisted by a PDA food database, for patients with type II diabetes. The results support the feasibility of implementing a fully powered RCT to explore the impact of a PDA-assisted low-GI intervention on glycemic control in type II diabetes. There were mixed reports regarding the usefulness of the PDAs; however, participants offered helpful suggestions for further development. Glycemic response is influenced by several factors including the nature of the monosaccharides absorbed, the amount of carbohydrate consumed, the rate of absorption, and colonic fermentation (Wolever, 2003) . In addition, several other factors affect the glycemic response to carbohydrates, including acid content (Ostman et al., 2005) , the proportion of certain nutritional components (fat, protein) in the mixed meal, the physical state of a food item (e.g., whole vs ground), the content of non-nutrients in foods like legumes (e.g., phytates), and, perhaps most important, the overall fiber content of a meal (Nuttall, 1993; Wursch and Pi-Sunyer, 1997) . The mechanisms of the proposed beneficial effects of dietary fiber and a low-GI diet on glucose control remain unclear, but they may include delayed gastric emptying, altered transit time in the small intestine, insulation of carbohydrate from digestive enzymes, and digestive enzyme inhibition. Reducing overall carbohydrate intake can increase postprandial serum free-fatty acids, whereas low-GI diets have been shown to both reduce serum free-fatty acids and improve glycemic control (Wolever, 2003) .
Results from our study are consistent with a recent metaanalysis of RCTs of low-GI diets among type I and type II diabetic patients suggesting that choosing low-GI foods in place of high-GI foods has a modest but clinically useful effect on medium-term glycemic control (Brand-Miller et al., 2003a) . Among type I diabetic patients (Weyman-Daum *P-values were from a mixed model for comparison of differences of least-squares means. Model was fit using HbA1c as dependent variable, time as independent variable and subject as random effect. The overall P-value for the model was 0.03. , 1987; Giacco et al., 2000; Gilbertson et al., 2003) , a low-GI diet resulted in significant decreases in postprandial plasma glucose levels, improved glycemic control and reduction in hypoglycemic events. Results were consistent among type II diabetic patients (Jenkins et al., 1988 (Jenkins et al., , 2002 Gulliford et al., 1989; Wolever et al., 1992; Jarvi et al., 1999; Tsihlias et al., 2000; Heilbronn et al., 2002; Kabir et al., 2002; Brynes et al., 2003; Gilbertson et al., 2003) , where low-GI diet improved plasma glucose control and had the added benefit of significantly decreasing cholesterol. Supporting the results from our study, a limited number of clinical trials have demonstrated that low-GI dietary educational interventions delivered by a clinical nutritionist can lead to improved metabolic control in patients with diabetes (Frost et al., 1994; Gilbertson et al., 2001 Gilbertson et al., , 2003 Rizkalla et al., 2004) . These reports are consistent with our findings. For example, in a study performed in Britain, 60 patients with type II diabetes were randomized to either a standard advice group or a low-GI advice group over a 12-week period (Frost et al., 1994) . Results demonstrated that patients in the low-GI diet group were successful in decreasing the GI of the food they consumed. Fasting blood glucose, fructosamine, total cholesterol and triglyceride levels showed a significantly greater decrease in the low-GI group as compared to those of the patients in the standard advice group.
As in our study, PDAs were used to monitor diet and blood glucose readings for 6 months in a pilot study with 20 diabetic patients (Tsang et al., 2001) . The dietary records were transmitted to a computerized diabetes monitoring system, and patients received immediate dietary feedback. Although no other intervention was involved, a significant improvement in glycemic control was reported. The study also found that 95% of the patients found PDAs easy to operate and 63% found them useful.
Critics of low-GI diets for diabetes often suggest that the concept of the GI is too complicated and restrictive to be of practical importance . Another potential limitation that is shared with carbohydrate counting is that, if not carefully chosen, a low-GI diet can be high in saturated fat and cholesterol, both of which can increase serum lipids and the associated cardiovascular disease risk (Neff, 2003) . Nutrition counseling can help ensure that the patient will choose a healthy and balanced low-GI diet, with results from initial trials suggesting that a structured low-GI diet can be a safe and usable tool for the management of diabetes, regardless of the patients' education levels (Frost et al., 1994; Gilbertson et al., 2001 Gilbertson et al., , 2003 .
PDAs have been used for gathering data in several studies (Taylor et al., 1990; Clarke et al., 1995; Shiffman et al., 1996; Tiplady et al., 1997; Johannes et al., 2000) . PDAs are ideally suited as an intervention tool for several reasons: they are compact and portable, and for the most part self-explanatory in their operation. PDA prices have decreased significantly, leading to a wider use in the population. The use of the PDA in our study also provided a channel for interaction between the user and the provider. Whereas further development of the software is ongoing, the option of immediate feedback on GI programmed into the PDA proved to be quite useful to Table 3 Within-subject changes in physiological, dietary, physical activity, and psychosocial variables in PDA study between baseline and 3-month point, between baseline and 6-month point and between 3-and 6-month points
Baseline
Change (3 months to baseline) Change (6 months to baseline) Change (6 months to 3 months) *P-values were from a mixed model from which we estimated mean within-subject differences over time. Models were fit using each physiological, dietary, physical activity and psychosocial variable as the dependent variable, time as the independent variable and subject as a random effect.
participants. Use of the PDA GI software addresses some of the perceived barriers (Franz, 2003) to the implementation of a low-GI nutrition intervention, as users are provided with readily accessible information on low-GI foods. As suggested by Henker and Colleagues (Henker et al., 2002) , PDAs have great potential to add to the effectiveness of protocol-driven treatment interventions. We observed a decrease in HbA1c and a change in overall GI score during the study. At the same time, we noted that total carbohydrate intake in the group as a whole also decreased from an average of 180 g/day at baseline to 140 g/ day at 6 months. Although the change did not achieve statistical significance (P ¼ 0.32), it could have contributed to the decrease in HbA1c levels. In addition, GL decreased 27 points between baseline and 6 months, so the change in HbA1c may also be related to the decrease in GL.
There are some weaknesses in our study, including lack of control group, small sample size, limited generalizability owing to population characteristics, need for refinement of the PDA food database and software, and potential measurement error of the GI score. First, owing to the pilot nature and design of our study, we were unable to examine which components (nutritionist or PDA) of the intervention were most important in achieving the results. Given that there was only one arm, our results could be explained by the combination of the intervention, placebo effects, and regression to the mean. Second, firm conclusions about effectiveness cannot be derived from our data given the small sample size and demographic characteristics of the study population. The fact that changes were generally in a consistently favorable direction, and that some changes were large enough to be statistically significant, however, is encouraging and indicates that a larger study is warranted. Participants were primarily white, highly educated, above average income levels and, although about half had no PDA experience, most had very positive attitudes towards the possibility that the PDAs would help them. Thus, generalizability is limited. This pilot study provided important information on efficacy, rather than effectiveness. We are investigating this further in a more diverse population, which is currently underway. Third, the PDA database and software require further development. The PDA development would include expansion of the database to increase patient satisfaction with their ability to obtain information on common foods, and an automated and personalized feedback system, in as close to real time as possible. Finally, structured assessment instruments, such as the 7DDR, used in our pilot study, have been associated with a variety of measurement errors (Hebert et al., 1997a (Hebert et al., , 2001 (Hebert et al., , 2002 with particular concern regarding the estimation of the GI. Collapsing foods into groups, rather than using specific foods and food quantities, could increase measurement error of GI with the 7DDR. Therefore, several 24-h diet recalls, which utilize the multiple pass recall methodology, may generate greater accuracy in future studies; however, this is more labor intensive.
Strengths of this pilot study include the fact that it was conducted in the clinical, 'real-world' setting, and that it attempted to address the perceived barriers to implementation of the GI score concept, using a technological device that is gaining acceptability in the general population.
The Dietary Guidelines for Americans (Marlett et al., 2002 ; US Department of Health and Human Services, 2005) stress an increase in consumption of whole grains, dietary fiber, fruit and vegetables, all of which are intrinsic to the low-GI diet, but are not necessarily part of the carbohydrate counting method. Optimal dietary management of diabetes may involve a combination of the two: decreasing the GI score of the diet, as well as the amount of carbohydrates consumed per day.
Diet is a fundamental component in the management of type II diabetes, but adherence to dietary recommendations is a challenging issue. Refinements in instruments that foster adherence are urgently needed. Technological devices such as the PDAs to promote adherence to dietary interventions via facilitation of food choices and real-time feedback appear to improve diabetes control.
In conclusion, results of this pilot study support the feasibility of implementing a nutritionist-delivered, PDAassisted, low-GI dietary intervention for patients with poorly controlled type II diabetes. Randomized controlled trials testing the efficacy of PDA-assisted low-GI diet on glycemic control are justified. On the other hand, although participants' perceptions regarding the practicality of the PDAs were positive overall, a more comprehensive GI database with 'real-time' personalized feedback is needed.
